Disease · MONDO_0002508
gingivitis
6 sourcesdiseases-2026-09-18-0.1.0
Cite this record
ConductScience Library. gingivitis. Diseases, record MONDO_0002508. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0002508
On this page
Disease
Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.
- Other names
- Gingival inflammation, Inflamed gums, Red and swollen gums, gingiva inflammation, inflammation of gingiva
- Open Targets
Drugs40
The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
| Drug | ChEMBL ID | Type | Open Targets' stage | Stage reported by | Reports | Of them trials | Trials shown here | Source |
|---|---|---|---|---|---|---|---|---|
| STANNOUS FLUORIDE | CHEMBL1909079 | Small molecule | Approval | DailyMed | 40 | 29 | 28 | Drugs and targets |
| CHLORHEXIDINE GLUCONATE | CHEMBL4297088 | Small molecule | Approval | DailyMed | 37 | 11 | 11 | Drugs and targets |
| SODIUM FLUORIDE | CHEMBL1528 | Small molecule | Approval | DailyMed | 11 | 9 | 8 | Drugs and targets |
| SODIUM MONOFLUOROPHOSPHATE | CHEMBL1908359 | Small molecule | Approval | DailyMed | 11 | 8 | 8 | Drugs and targets |
| HYDROGEN PEROXIDE | CHEMBL71595 | Small molecule | Approval | DailyMed | 8 | 6 | 6 | Drugs and targets |
| CHLORHEXIDINE | CHEMBL790 | Small molecule | Phase 3 | ClinicalTrials.gov | 32 | 32 | 32 | Drugs and targets |
| CETYLPYRIDINIUM CHLORIDE | CHEMBL2003538 | Small molecule | Phase 3 | ClinicalTrials.gov | 14 | 14 | 14 | Drugs and targets |
| FLUORIDE | CHEMBL1232767 | Small molecule | Phase 3 | ClinicalTrials.gov | 14 | 14 | 14 | Drugs and targets |
| TRICLOSAN | CHEMBL849 | Small molecule | Phase 3 | ClinicalTrials.gov | 8 | 8 | 7 | Drugs and targets |
| THYMOL | CHEMBL29411 | Small molecule | Phase 3 | ClinicalTrials.gov | 6 | 6 | 1 | Drugs and targets |
1 to 10 of 40
See all 40 drugsTargets6
The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.
| Target | Protein | Its drugs that act on it | Mechanisms | Highest stage of those drugs | Gene in Genes | Source |
|---|---|---|---|---|---|---|
| AR | Androgen receptor | 1 | Androgen Receptor antagonist | Unknown | https://conductscience.org/library/genes/367 | Drugs and targets |
| C3 | Complement C3 | 1 | Complement C3 inhibitor | Phase 2 | https://conductscience.org/library/genes/718 | Drugs and targets |
| ESR1 | Estrogen receptor | 1 | Estrogen receptor alpha agonist | Unknown | https://conductscience.org/library/genes/2099 | Drugs and targets |
| NR3C1 | Glucocorticoid receptor | 1 | Glucocorticoid receptor antagonist | Unknown | https://conductscience.org/library/genes/2908 | Drugs and targets |
| PGR | Progesterone receptor | 1 | Progesterone receptor agonist | Unknown | https://conductscience.org/library/genes/5241 | Drugs and targets |
| VDR | Vitamin D3 receptor | 1 | Vitamin D receptor agonist | Phase 1 | https://conductscience.org/library/genes/7421 | Drugs and targets |
Trials111
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 3 more are not shown, since the checks do not confirm them.
| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03988374 | Clinical Efficacy Evaluation of Three Dentifrices | Phase 2 | 319 | 2021-08-23 | Gingival Inflammation and Bleeding, Dental Plaque | SODIUM BICARBONATE | Its record names the disease | ClinicalTrials.gov |
| NCT02750943 | Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease | Not applicable | 253 | 2016-11-11 | Gingivitis | STANNOUS FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT02207907 | To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste | Phase 2 | 247 | 2017-02-17 | Oral Hygiene | SODIUM BICARBONATE, SODIUM FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT02207400 | To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms | Phase 2 | 246 | 2016-07-26 | Oral Hygiene | SODIUM BICARBONATE, SODIUM FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT06660069 | A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation | Not applicable | 199 | 2026-03-18 | Dental Plaque, Gingivitis | CETYLPYRIDINIUM CHLORIDE, STANNOUS FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT05654662 | A Clinical Study Investigating the Effects of a Dentifrice Containing 67% Sodium Bicarbonate When Used Twice Daily for 12 Weeks on Gingivitis Treatment and Plaque Removal | Not applicable | 197 | 2025-01-13 | Gingivitis, Dental Plaque | SODIUM BICARBONATE | Its record names the disease | ClinicalTrials.gov |
| NCT06602466 | A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health | Not applicable | 175 | 2026-01-22 | Dental Plaque, Gingivitis | STANNOUS FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT02243046 | The Clinical Investigation of a Zinc Based Toothpaste in Reducing Plaque and Gingivitis | Phase 2 | 162 | 2016-05-04 | Dental Plaque and Gingivitis | TRICLOSAN | Its record names the disease | ClinicalTrials.gov |
| NCT06143670 | A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks | Not applicable | 159 | 2025-03-21 | Gingivitis | SODIUM FLUORIDE, STANNOUS FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT04050722 | A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks | Phase 4 | 130 | 2020-11-19 | Gingivitis | SODIUM FLUORIDE, STANNOUS FLUORIDE | Its record names the disease | ClinicalTrials.gov |
1 to 10 of 111
See all 111 trialsComparisons in its trials18
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Stannous Fluoride vs Sodium Monofluorophosphate: serious adverse events | 0 of 125 | 0 of 128 | 253 | NCT02750943 | Trial comparisons |
| Sodium Bicarbonate Dentrifice vs 0% Sodium Bicarbonate Dentrifice: serious adverse events | 0 of 124 | 0 of 123 | 247 | NCT02207907 | Trial comparisons |
| Sodium Bicarbonate and Sodium Fluoride Dentifrice vs Sodium Fluoride Dentifrice: serious adverse events | 0 of 123 | 0 of 123 | 246 | NCT02207400 | Trial comparisons |
| Test Product (Corsodyl Original Toothpaste) vs Reference Product (Colgate Cavity Protection Toothpaste): deaths from any cause | 0 of 94 | 0 of 96 | 190 | NCT05654662 | Trial comparisons |
| Test Product (Corsodyl Original Toothpaste) vs Reference Product (Colgate Cavity Protection Toothpaste): serious adverse events | 0 of 94 | 0 of 96 | 190 | NCT05654662 | Trial comparisons |
| Test Toothpaste vs Reference Toothpaste (Negative Control): deaths from any cause | 0 of 78 | 0 of 83 | 161 | NCT06602466 | Trial comparisons |
| Test Toothpaste vs Reference Toothpaste (Negative Control): serious adverse events | 0 of 78 | 0 of 83 | 161 | NCT06602466 | Trial comparisons |
| Test Product vs Reference Product (Negative Control): deaths from any cause | 0 of 76 | 0 of 76 | 152 | NCT06143670 | Trial comparisons |
| Test Product vs Reference Product (Negative Control): serious adverse events | 0 of 76 | 0 of 76 | 152 | NCT06143670 | Trial comparisons |
| Sensodyne Repair and Protect (Test Dentifrice) vs Colgate Cavity Protection (Negative Control Dentifrice): deaths from any cause | 0 of 65 | 0 of 65 | 130 | NCT04050722 | Trial comparisons |
1 to 10 of 18
See all 18 comparisons in its trialsPapers from its trials33
The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Data dates
The date of each source this release read.
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this disease from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0002508
GET https://conductscience.org/api/diseases/v1/MONDO_0002508/drugs?page=2